These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 31220951)

  • 1. Proteomic signatures of neuroinflammation in Alzheimer's disease, multiple sclerosis and ischemic stroke.
    Thygesen C; Larsen MR; Finsen B
    Expert Rev Proteomics; 2019 Jul; 16(7):601-611. PubMed ID: 31220951
    [No Abstract]   [Full Text] [Related]  

  • 2. Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's disease.
    Higginbotham L; Ping L; Dammer EB; Duong DM; Zhou M; Gearing M; Hurst C; Glass JD; Factor SA; Johnson ECB; Hajjar I; Lah JJ; Levey AI; Seyfried NT
    Sci Adv; 2020 Oct; 6(43):. PubMed ID: 33087358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic Approaches to Decipher Mechanisms Underlying Pathogenesis in Multiple Sclerosis Patients.
    Singh V; Tripathi A; Dutta R
    Proteomics; 2019 Aug; 19(16):e1800335. PubMed ID: 31119864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic alterations in patients with atopic dermatitis.
    Obi A; Rothenberg-Lausell C; Levit S; Del Duca E; Guttman-Yassky E
    Expert Rev Proteomics; 2024; 21(5-6):247-257. PubMed ID: 38753434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-generation proteomics technologies in Alzheimer's disease: from clinical research to routine diagnostics.
    Weiner S; Blennow K; Zetterberg H; Gobom J
    Expert Rev Proteomics; 2023; 20(7-9):143-150. PubMed ID: 37701966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Quantitative Proteomic Approach for High-Throughput Quantitative Profiling of Small GTPases in Brain Tissues of Alzheimer's Disease Patients.
    Huang M; Darvas M; Keene CD; Wang Y
    Anal Chem; 2019 Oct; 91(19):12307-12314. PubMed ID: 31460748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-Based Classifier to Predict Conversion from Clinically Isolated Syndrome to Multiple Sclerosis.
    Borràs E; Cantó E; Choi M; Maria Villar L; Álvarez-Cermeño JC; Chiva C; Montalban X; Vitek O; Comabella M; Sabidó E
    Mol Cell Proteomics; 2016 Jan; 15(1):318-28. PubMed ID: 26552840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic, proteomic, and systems biology approaches in biomarker discovery for multiple sclerosis.
    Chase Huizar C; Raphael I; Forsthuber TG
    Cell Immunol; 2020 Dec; 358():104219. PubMed ID: 33039896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders.
    Yang C; Farias FHG; Ibanez L; Suhy A; Sadler B; Fernandez MV; Wang F; Bradley JL; Eiffert B; Bahena JA; Budde JP; Li Z; Dube U; Sung YJ; Mihindukulasuriya KA; Morris JC; Fagan AM; Perrin RJ; Benitez BA; Rhinn H; Harari O; Cruchaga C
    Nat Neurosci; 2021 Sep; 24(9):1302-1312. PubMed ID: 34239129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Adipokines in the Pathologies of the Central Nervous System.
    Huber K; Szerenos E; Lewandowski D; Toczylowski K; Sulik A
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid metabolomics: detection of neuroinflammation in human central nervous system disease.
    Yan J; Kuzhiumparambil U; Bandodkar S; Dale RC; Fu S
    Clin Transl Immunology; 2021; 10(8):e1318. PubMed ID: 34386234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple Sclerosis Biomarker Discoveries by Proteomics and Metabolomics Approaches.
    Jafari A; Babajani A; Rezaei-Tavirani M
    Biomark Insights; 2021; 16():11772719211013352. PubMed ID: 34017167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of platelets in neuroinflammation: a wide-angle perspective.
    Horstman LL; Jy W; Ahn YS; Zivadinov R; Maghzi AH; Etemadifar M; Steven Alexander J; Minagar A
    J Neuroinflammation; 2010 Feb; 7():10. PubMed ID: 20128908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing Neurological Health: Insights into Aging, Immunity, and Vascular Dynamics.
    Xu T; Ye J; Gan L; Deng S; Guo Y; Tang Y
    Aging Dis; 2024 May; 15(3):939-944. PubMed ID: 38722789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial reverse electron transport in myeloid cells perpetuates neuroinflammation.
    Peruzzotti-Jametti L; Willis CM; Hamel R; Krzak G; Reisz JA; Prag HA; Wu V; Xiang Y; van den Bosch AMR; Nicaise AM; Roth L; Bates GR; Huang H; Vincent AE; Frezza C; Viscomi C; Marioni JC; D'Alessandro A; Takats Z; Murphy MP; Pluchino S
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation.
    Johnson ECB; Dammer EB; Duong DM; Ping L; Zhou M; Yin L; Higginbotham LA; Guajardo A; White B; Troncoso JC; Thambisetty M; Montine TJ; Lee EB; Trojanowski JQ; Beach TG; Reiman EM; Haroutunian V; Wang M; Schadt E; Zhang B; Dickson DW; Ertekin-Taner N; Golde TE; Petyuk VA; De Jager PL; Bennett DA; Wingo TS; Rangaraju S; Hajjar I; Shulman JM; Lah JJ; Levey AI; Seyfried NT
    Nat Med; 2020 May; 26(5):769-780. PubMed ID: 32284590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer's Disease Progression.
    Bai B; Wang X; Li Y; Chen PC; Yu K; Dey KK; Yarbro JM; Han X; Lutz BM; Rao S; Jiao Y; Sifford JM; Han J; Wang M; Tan H; Shaw TI; Cho JH; Zhou S; Wang H; Niu M; Mancieri A; Messler KA; Sun X; Wu Z; Pagala V; High AA; Bi W; Zhang H; Chi H; Haroutunian V; Zhang B; Beach TG; Yu G; Peng J
    Neuron; 2020 Mar; 105(6):975-991.e7. PubMed ID: 31926610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation-related plasma and CSF biomarkers for multiple sclerosis.
    Huang J; Khademi M; Fugger L; Lindhe Ö; Novakova L; Axelsson M; Malmeström C; Constantinescu C; Lycke J; Piehl F; Olsson T; Kockum I
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12952-12960. PubMed ID: 32457139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer's disease.
    Whelan CD; Mattsson N; Nagle MW; Vijayaraghavan S; Hyde C; Janelidze S; Stomrud E; Lee J; Fitz L; Samad TA; Ramaswamy G; Margolin RA; Malarstig A; Hansson O
    Acta Neuropathol Commun; 2019 Nov; 7(1):169. PubMed ID: 31694701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma proteome in multiple sclerosis disease progression.
    Malekzadeh A; Leurs C; van Wieringen W; Steenwijk MD; Schoonheim MM; Amann M; Naegelin Y; Kuhle J; Killestein J; Teunissen CE
    Ann Clin Transl Neurol; 2019 Sep; 6(9):1582-1594. PubMed ID: 31364818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.